Cumulus Neuroscience Presents Remote Brain Monitoring Data

Cumulus Neuroscience presented interim data at the ISCTM 2026 Autumn Conference, showcasing the usability and adherence of its remote, multimodal brain monitoring system in patients with borderline personality disorder and therapy-resistant depression.

The data indicated a high level of engagement from participants using the remote monitoring technology. Additionally, a brief two-minute digital cognitive task performed comparably to established clinical benchmarks for pre-enrolling patients in Alzheimer's disease trials.

These preliminary findings suggest the potential of Cumulus Neuroscience's technology to enhance brain health monitoring and patient selection in neurological and psychiatric research. The company is continuing its research and data collection to further validate its findings.